235
15 - novembre 2018 - Minuti cancer/earlydetection/if-test-results-not-normal.html. Accessed March 6, 2017. 18. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI- targeted or standard biopsy for prostate-cancer diagnosis. NEngl J Med. 2018;378(19):1767-1777. 19. American Joint Committee onCancer. Prostate cancer stag- ing. 7th ed. https://cancerstaging.org/references-tools/quickref- erences/Documents/ProstateSmall.pdf. AccessedMarch 6, 2017. 20. Tsao CK, Gray KP, Nakabayashi M, et al. Patients with biopsyGleason 9 and 10 prostate cancer have significantly worse outcomes compared to patients with Gleason 8 disease. J Urol. 2015;194(1):91-97. 21. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grad- ing patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244-252. 22. Post PN, Hansen BE, Kil PJ, Janssen-Heijnen ML, Co- ebergh JW. The independent prognostic value of comorbidity amongmen aged < 75 years with localized prostate cancer: a pop- ulation-based study. BJU Int. 2001;87(9):821-826. 23. Mohan R, Beydoun H, Davis J, Lance R, Schellhammer P. Feasibility of using guidelines to choose treatment for prostate cancer. Can J Urol. 2010;17(1):4975-4984. 24. Hamdy FC, Donovan JL, Lane JA, et al.; ProtecT Study Group. 10-year outcomes after monitoring, surgery, or radio- therapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415-1424. 25. Agency for Healthcare Research and Quality. Treating lo- calized prostate cancer. A review of the research for adults. Jan- uary 21, 2016. https://www.effectivehealthcare.ahrq.gov/top- ics/prostate-cancer-therapiesupdate/consumer. AccessedMarch 6, 2017. 26. Kittel JA, Reddy CA, Smith KL, et al. Long-term efficacy and toxicity of low-dose-rate 125I prostate brachytherapy as monotherapy in low-, intermediate-, and high-risk prostate can- cer. Int J Radiat Oncol Biol Phys. 2015;92(4):884-893. 27. American Cancer Society. Radiation therapy for prostate cancer. https://www.cancer.org/cancer/prostate-cancer/treat- ing/radiationtherapy.html. Accessed September 10, 2017. 28. Klein EA. Radical prostatectomy for localized prostate can- cer.UpdatedSeptember 25, 2017. https://www.uptodate.com/con- tents/radicalprostatectomy-for-localized-prostate-cancer [login required]. Accessed July 31, 2017. 29. ZelefskyMJ, Eastham JA, Cronin AM, et al. Metastasis af- ter radical prostatectomy or external beam radiotherapy for pa- tients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for casemix. JClinOncol. 2010;28(9):1508- 1513. 30. National Cancer Institute. Prostate cancer treatment (PDQ)- healthprofessional version.Treatment optionoverview for prostate cancer.UpdatedDecember 8, 2017. https://www.cancer.gov/types/ prostate/hp/prostate-treatment-pdq#section/_62. AccessedMarch 6, 2017. 31. Wisenbaugh ES, Andrews PE, Ferrigni RG, et al. Proton beam therapy for localized prostate cancer 101: basics, contro- versies, and facts. Rev Urol. 2014;16(2):67-75. 32. Agency for Healthcare Research andQuality.Therapies for clinically localized prostate cancer. January 21, 2016. http://ef- fective healthcare. ahrq.gov/topics/prostate-cancer-therapies-up- date/clinician. AccessedMarch 6, 2017. 33. Klotz L. Active surveillance formenwith low-risk, clinically localizedprostate cancer.UpToDate. https://www.uptodate.com/con- tents/activesurveillance-for-men-with-low-risk-clinically-local- ized-prostate-cancer [login required]. Accessed April 3, 2017. 34. American Society of Clinical Oncology. Prostate cancer: treatment options. http://www.cancer.net/cancer-types/prostate- cancer/treatmentoptions. AccessedMarch 6, 2017. 35. van den BerghRC, Essink-BotML, RoobolMJ, et al. Anx- iety and distress during active surveillance for early prostate can- cer. Cancer. 2009;115(17):3868-3878. 36. Bhatnagar V, Kaplan RM. Treatment options for prostate cancer: evaluating the evidence. Am Fam Physician. 2005;71(10):1915-1922.
Made with FlippingBook
RkJQdWJsaXNoZXIy MTkxMjE=